FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
15/11/2025
Voltar para busca
Dado oficial do USPTO
BIO2Q
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
46
Atualização mais recente
03/04/2026
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
41, 42
Data de depósito
12/05/2023
Data de registro
15/04/2025
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
15/04/2025
Última transação
03/04/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
3
Tipo de titular
99
Localização do titular
JP
Examinador
HOWARD, PARKER WALDRIP
Unidade examinadora
N90
Localização atual
FILE REPOSITORY (FRANCONIA)
Descrição da marca
The mark consists of the wording "BIO20_" where the "BI" and "20" is in blue, the short underline under the "O" is also in blue and the "O" consists of a circle that features shades of blue, green, and red.
Titulares e representantes
Titulares
K. U. (pessoa física)
Representantes
Jeffrey H. Handelsman Greenblum & Bernstein, P.L.C.
Classificação técnica
Classes Nice
Classe 41Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 41
Educational services in the nature of providing instruction in the field of life sciencemanufacturing processes of pharmaceuticals and analysis of microorganisms and information services relating thereto; arrangingconducting and organization of seminars in the fields of life sciencemanufacturing processes of pharmaceuticals and analysis of microorganisms and information services relating theretoproviding information about seminars in the fields of life sciencemanufacturing processes of pharmaceuticals and analysis of microorganisms; development of educational curricula in the field of sciencemedicinehealthbiomedicinepharmacologybiology and physics and information services relating theretoproviding information about development of educational curricula in the field of sciencemedicinehealthbiomedicinepharmacologybiology and physics; providing information in the field of education; research in the field of education; publishing of journalsbooks and handbooks in the field of medicine; publication of booksperiodical publicationsmagazinesnewspapers and newsletters; educational services relating to anti-agingproviding instruction in the field of anti-aging; provision of educational courses in the field of diet and health care; higher educationacademiclinguistic and vocational education and training servicesproviding courses of instruction in the academic field of science for the purpose of academic study; training for handling scientific instruments and apparatus for research in laboratories; educational examination services; arranging and conducting of symposiums in the fields of life sciencemanufacturing processes of pharmaceuticals and analysis of microorganisms; arranging and conducting of workshops in the fields of life sciencemanufacturing processes of pharmaceuticals and analysis of microorganisms; planningarrangingorganization and conducting of seminarssymposiumsconferenceslecturesworkshops and research meetings in the fields of life sciencemanufacturing processes of pharmaceuticals and analysis of microorganisms; organization of exhibitions for cultural or educational purposes; research library services; dubbing; providing on-line magazines in the fields of life sciencemanufacturing processes of pharmaceuticals and analysis of microorganismsnot downloadable; providing on-line newsletters in the fields of life sciencemanufacturing processes of pharmaceuticals and analysis of microorganismsnot downloadable; providing online non-downloadable electronic publications in the nature of books and brochures in the fields of life sciencemanufacturing processes of pharmaceuticals and analysis of microorganisms; providing online non-downloadable videos in the fields of life sciencemanufacturing processes of pharmaceuticals and analysis of microorganisms; providing television programmesnot downloadablevia video-on-demand services; production of videotape film in the field of educationcultureentertainment or sportsnot for movies or television programs and not for advertising or publicity; rental of sound recordings; rental of videotapes; photography; interpretation and translation services
Classe 42
Research and development in the field of microorganisms and cells and information services relating thereto; research services in the field of proteinsantibodiesmicroorganisms and cells and information services relating theretoproviding information about research services in the field of proteinsantibodiesmicroorganisms and cells; chemicalbiochemicalbiological and bacteriological research and analysis and information services relating theretoproviding information about chemicalbiochemicalbiological and bacteriological research and analysis; biological research; biological research laboratory services; biomedical research services; biotechnological research; biology consultancy; research in the fields of chemistrybiology and physics; chemistry serviceschemistry consultationresearch in the field of chemistry and research laboratory analysis services in the field of chemistry; providing information in the nature of scientific research in the fields of biochemistry and biotechnology; research in the field of nanobiotechnology; biotechnology research; clinical trialsscientific research in the nature of conducting clinical trials for others; medical research; bacteriological research; stem cell research services; pharmaceutical research; providing information about medical and scientific research in the field of pharmaceuticals; provision of information in the field of technological research; research in the field of human reproductive science; scientific services in the field of the isolation and cultivation of human tissues and cells; structural and functional analysis of genomes; research and development services in the field of immunology; research and development services in the field of antibodies; cell culture services for scientific and research purposesfor others; conducting clinical trials for othersscientific research; design and development of endoprostheses; research and development of new products for others; providing information in the field of product development; research and development services relating to medicines; preparation of biological samples for research purposes; quantum computingconsultancy in the field of quantum computing and research in the field of quantum computing; scientific research in the field of quantum computing; research in the field of artificial intelligence technology; computer programming; software engineering services for data processing; development of computer platforms; rental of laboratory apparatus and instruments
Publicações
Histórico de despachos e eventos da marca no USPTO.
46 publicações encontradas
FICS
FINAL DISPOSITION NOTICE SENT TO IB
28/10/2025
FIMP
FINAL DISPOSITION PROCESSED
28/10/2025
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
15/07/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
15/04/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
15/04/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
25/02/2025
PUBO
PUBLISHED FOR OPPOSITION
25/02/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
19/02/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
30/01/2025
XAEC
EXAMINER'S AMENDMENT ENTERED
30/01/2025
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
30/01/2025
GNEA
EXAMINERS AMENDMENT E-MAILED
30/01/2025
CNEA
EXAMINERS AMENDMENT -WRITTEN
30/01/2025
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
14/12/2024
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
27/11/2024
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
27/11/2024
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
28/10/2024
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
24/09/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
28/08/2024
XAEC
EXAMINER'S AMENDMENT ENTERED
28/08/2024
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
28/08/2024
GNEA
EXAMINERS AMENDMENT E-MAILED
28/08/2024
CNEA
EXAMINERS AMENDMENT -WRITTEN
28/08/2024
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
09/07/2024
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
25/06/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/06/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
30/05/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
30/05/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
30/05/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
30/05/2024
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
30/05/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
30/05/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
30/05/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
30/05/2024
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
30/05/2024
RFNT
REFUSAL PROCESSED BY IB
26/03/2024
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
04/03/2024
RFRR
REFUSAL PROCESSED BY MPU
04/03/2024
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
10/02/2024
CNRT
NON-FINAL ACTION WRITTEN
09/02/2024
DOCK
ASSIGNED TO EXAMINER
07/02/2024
NREP
NEW REPRESENTATIVE AT IB RECEIVED
22/12/2023
MAFR
APPLICATION FILING RECEIPT MAILED
07/07/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/07/2023
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
29/06/2023
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace BIO2Q ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.